In approximately half of the EOC patients with a BRCA1/2 PV detected in the tumor, the PV is of germline origin [11–13] and their relatives are invited for counseling and testing, regardless of the cancer history of the relatives. This evidence concerns the gene BRCA1 and neoplasm.